| Record ID | ia:antiangiogenicag00teic |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/antiangiogenicag00teic/antiangiogenicag00teic_marc.xml |
| Download MARC binary | https://www.archive.org/download/antiangiogenicag00teic/antiangiogenicag00teic_meta.mrc |
LEADER: 00948pam 2200277 a 4500
001 98045812
003 DLC
005 19991022094626.0
008 980930s1999 njua 001 0 eng c
010 $a 98045812
020 $a0896036413 (alk. paper)
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC271.N46$bA58 1999
060 10 $aQZ 267$bA628 1999
082 00 $a616.99/4061$221
245 00 $aAntiangiogenic agents in cancer therapy /$cedited by Beverly A. Teicher.
260 $aTotowa, N.J. :$bHumana Press,$cc1999.
300 $axi, 450 p. :$bill. ;$c26 cm.
440 0 $aCancer drug discovery and development
504 $aIncludes bibliographical references and index.
650 0 $aNeovascularization inhibitors.
650 0 $aCancer$xChemotherapy.
650 12 $aNeoplasms$xdrug therapy.
650 22 $aNeovascularization, Pathologic$xdrug therapy.
650 22 $aAntineoplastic Agents$xtherapeutic use.
700 1 $aTeicher, Beverly A.,$d1952-